Aurinia Pharmaceuticals

Aurinia Pharmaceuticals AUPH Stock

$15.12   -1.818180%
Add to favorites
Market Cap
$2.03B
LOW - HIGH [24H]
$15.11 - $15.45
VOLUME [24H]
$120.76K
P/E Ratio
6.63
Earnings per share
$2.28
ISIN
CA05156V1022
Price   Prediction

Aurinia Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

Aurinia Pharmaceuticals (AUPH) stock price today is 15.12 USD on Tech Market Middle (-1.82% on the day). Updated .

Aurinia Pharmaceuticals AUPH Financial and Trading Overview

Aurinia Pharmaceuticals stock price 15.12 USD
Previous Close 15.48 USD
Open 15.3 USD
Bid 12.84 USD x 100
Ask 17.28 USD x 100
Day's Range 15.19 - 15.44 USD
52 Week Range 13.52 - 19.25 USD
Volume 833.16K USD
Avg. Volume 897.18K USD
Market Cap 2.06B USD
Beta (5Y Monthly) 1.342
PE Ratio (TTM) 6.754386
EPS (TTM) 2.28 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 18.5 USD

AUPH Valuation Measures

Enterprise Value 1.64B USD
Trailing P/E 6.754386
Forward P/E 13.275862
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.4138503
Price/Book (mrq) 3.1383736
Enterprise Value/Revenue 5.084
Enterprise Value/EBITDA 8.822

Trading Information

Aurinia Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.342
52-Week Change 1.31%
S&P500 52-Week Change 10.51%
52 Week High 19.25 USD
52 Week Low 13.52 USD
50-Day Moving Average 16.46 USD
200-Day Moving Average 15.74 USD

AUPH Share Statistics

Avg. Volume (3 month) 897.18K USD
Avg. Daily Volume (10-Days) 1.01M USD
Shares Outstanding 134M
Float 130.16M
Short Ratio 8.97
% Held by Insiders 6.73%
% Held by Institutions 60.11%
Shares Short 7.14M
Short % of Float 5.87%
Short % of Shares Outstanding 5.33%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 97.67%
Operating Margin (ttm) 51.61%
Gross Margin 75.69%
EBITDA Margin 57.63%

Management Effectiveness

Return on Assets (ttm) 15.34%
Return on Equity (ttm) 61.42%

Income Statement

Revenue (ttm) 321.74M USD
Revenue Per Share (ttm) 2.44 USD
Quarterly Revenue Growth (yoy) 13.90%
Gross Profit (ttm) 243.54M USD
EBITDA 185.42M USD
Net Income Avi to Common (ttm) 314.27M USD
Diluted EPS (ttm) 2.28
Quarterly Earnings Growth (yoy) 0.50%

Balance Sheet

Total Cash (mrq) 486.53M USD
Total Cash Per Share (mrq) 3.63 USD
Total Debt (mrq) 58.66M USD
Total Debt/Equity (mrq) 8.92 USD
Current Ratio (mrq) 6.123
Book Value Per Share (mrq) 4.907

Cash Flow Statement

Operating Cash Flow (ttm) 177.16M USD
Levered Free Cash Flow (ttm) 140.48M USD

Profile of Aurinia Pharmaceuticals

Country United States
State AB
City Edmonton
Address #140, 14315 – 118 Avenue
ZIP T5L 4S6
Phone 250 744 2487
Website https://www.auriniapharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 128

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Q&A For Aurinia Pharmaceuticals Stock

What is a current AUPH stock price?

Aurinia Pharmaceuticals AUPH stock price today per share is 15.12 USD.

How to purchase Aurinia Pharmaceuticals stock?

You can buy AUPH shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Aurinia Pharmaceuticals?

The stock symbol or ticker of Aurinia Pharmaceuticals is AUPH.

Which industry does the Aurinia Pharmaceuticals company belong to?

The Aurinia Pharmaceuticals industry is Biotechnology.

How many shares does Aurinia Pharmaceuticals have in circulation?

The max supply of Aurinia Pharmaceuticals shares is 134M.

What is Aurinia Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Aurinia Pharmaceuticals PE Ratio is 6.63157900 now.

What was Aurinia Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Aurinia Pharmaceuticals EPS is 2.28 USD over the trailing 12 months.

Which sector does the Aurinia Pharmaceuticals company belong to?

The Aurinia Pharmaceuticals sector is Healthcare.

Aurinia Pharmaceuticals AUPH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24356.87 USD —
+0.12
2.55B USD — 24268.03 USD — 24538.78 USD — — 2.55B USD —
us US Tech Composite Total Return XCMP US 30153.42 USD —
+0.3
— — 29990.36 USD — 30324.94 USD — — — —
us US Tech Developed ex US SC NTR G NQDMXUSSCGBPN US 1704.47 GBP 2263.58 USD
0
— — 1704.47 GBP 2263.57 USD 1704.47 GBP 2263.57 USD — — —
us US Tech Biotechnology NBI US 6986.34 USD —
-0.45
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1327.34 USD —
-0.42
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech Global Market Composite NQGM US 1839.09 USD —
+0.18
— — 1832.56 USD — 1855.92 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$69.46B
Total volume
BTC 58.15%   •   ETH 9.90%
Dominance
Select currency